Trade Eyenovia, Inc. - EYEN CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Trading Conditions
| Spread | - | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.024068% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.001846% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 20% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
Key Stats
| Prev. Close* | N/A |
| Open* | N/A |
| 1-Year Change* | N/A |
| Day's Range* | N/A |
| 52 wk Range | 1.50-3.34 |
| Average Volume (10 days) | 103.72K |
| Average Volume (3 months) | 4.11M |
| Market Cap | 107.64M |
| P/E Ratio | -100.00K |
| Shares Outstanding | 36.12M |
| Revenue | 10.00M |
| EPS | -0.56 |
| Dividend (Yield %) | N/A |
| Beta | 1.67 |
| Next Earnings Date | Mar 30, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
Eyenovia, Inc. Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Annual
- Quarterly
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Total revenue | 14 | 2 | 0 | 0 | 0 |
| Revenue | 14 | 2 | 0 | ||
| Total Operating Expense | 26.4403 | 21.7892 | 21.3085 | 17.2564 | 5.13237 |
| Selling/General/Admin. Expenses, Total | 10.7842 | 7.69759 | 7.20051 | 6.13618 | 1.31564 |
| Research & Development | 14.2979 | 13.1962 | 14.0927 | 11.1011 | 3.79127 |
| Depreciation / Amortization | 0.22156 | 0.09542 | 0.01534 | 0.01913 | 0.02547 |
| Operating Income | -12.4403 | -19.7892 | -21.3085 | -17.2564 | -5.13237 |
| Interest Income (Expense), Net Non-Operating | -0.38524 | 0.00936 | 0.15179 | 0.00334 | 0.00238 |
| Net Income Before Taxes | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Net Income After Taxes | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Net Income Before Extra. Items | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Net Income | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Income Available to Common Excl. Extra. Items | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Income Available to Common Incl. Extra. Items | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Dilution Adjustment | |||||
| Diluted Net Income | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Diluted Weighted Average Shares | 26.3241 | 21.0547 | 14.3497 | 9.47671 | 9.93677 |
| Diluted EPS Excluding Extraordinary Items | -0.48543 | -0.93898 | -1.47437 | -1.82058 | -0.51626 |
| Dividends per Share - Common Stock Primary Issue | |||||
| Diluted Normalized EPS | -0.50303 | -0.93898 | -1.47437 | -1.82058 | -0.51626 |
| Total Extraordinary Items | 0 | ||||
| Cost of Revenue, Total | 1.6 | 0.8 | |||
| Gross Profit | 12.4 | 1.2 | |||
| Other, Net | 0.04718 | 0.01 | |||
| Unusual Expense (Income) | -0.46335 |
| Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | |
|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 10 | 0 |
| Revenue | 0 | 0 | 0 | 10 | 0 |
| Cost of Revenue, Total | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 10 | 0 |
| Total Operating Expense | 7.23023 | 7.12146 | 7.18755 | 6.88673 | 5.46171 |
| Selling/General/Admin. Expenses, Total | 3.35335 | 3.53459 | 3.47497 | 3.7115 | 2.373 |
| Research & Development | 3.87688 | 3.58687 | 3.71258 | 3.17523 | 3.55207 |
| Operating Income | -7.23023 | -7.12146 | -7.18755 | 3.11327 | -5.46171 |
| Interest Income (Expense), Net Non-Operating | -0.14905 | -0.15102 | -0.14505 | -0.18519 | -0.11861 |
| Other, Net | 0.07028 | 0.03338 | -0.00707 | 0.05519 | 0.01173 |
| Net Income Before Taxes | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
| Net Income After Taxes | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
| Net Income Before Extra. Items | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
| Net Income | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
| Income Available to Common Excl. Extra. Items | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
| Income Available to Common Incl. Extra. Items | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
| Diluted Net Income | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
| Diluted Weighted Average Shares | 34.6318 | 33.6449 | 30.0082 | 27.977 | 26.0535 |
| Diluted EPS Excluding Extraordinary Items | -0.21105 | -0.21516 | -0.24459 | 0.10663 | -0.21374 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Diluted Normalized EPS | -0.21105 | -0.21516 | -0.24459 | 0.10663 | -0.23152 |
| Unusual Expense (Income) | 0 | 0 | -0.46335 |
- Annual
- Quarterly
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Total Current Assets | 29.8769 | 33.3913 | 14.3493 | 19.861 | 5.28666 |
| Cash and Short Term Investments | 19.4618 | 28.3718 | 14.1526 | 19.7282 | 5.24951 |
| Cash | 19.4618 | 28.3718 | 14.1526 | 19.7282 | 5.24951 |
| Prepaid Expenses | 0.38663 | 0.2898 | 0.07737 | 0.13276 | 0.03715 |
| Total Assets | 31.6591 | 33.9068 | 14.6976 | 20.0155 | 5.64332 |
| Property/Plant/Equipment, Total - Net | 1.27123 | 0.39638 | 0.23054 | 0.03674 | 0.02796 |
| Property/Plant/Equipment, Total - Gross | 1.59963 | 0.57329 | 0.31203 | 0.10289 | 0.07498 |
| Accumulated Depreciation, Total | -0.32841 | -0.17691 | -0.08149 | -0.06615 | -0.04702 |
| Total Current Liabilities | 11.1725 | 18.1984 | 2.91166 | 3.09884 | 0.55265 |
| Accounts Payable | 1.6141 | 1.46167 | 1.54136 | 1.50952 | 0.24638 |
| Accrued Expenses | 2.32693 | 2.57974 | 1.31332 | 1.56769 | 0.29529 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 0.08109 | 14.0594 | 0.05698 | 0.02163 | 0.01098 |
| Total Liabilities | 11.1924 | 18.6029 | 2.95701 | 3.14043 | 0.55265 |
| Total Long Term Debt | 0 | 0.36581 | 0 | 0 | 0 |
| Other Liabilities, Total | 0.01995 | 0.03868 | 0.04535 | 0.04158 | 0 |
| Total Equity | 20.4666 | 15.3039 | 11.7406 | 16.8751 | 5.09067 |
| Redeemable Preferred Stock | 0 | 0 | 0 | ||
| Preferred Stock - Non Redeemable, Net | 0.00046 | ||||
| Common Stock | 0.00284 | 0.0025 | 0.00171 | 0.00115 | 0.00026 |
| Additional Paid-In Capital | 110.683 | 92.7423 | 69.41 | 53.3882 | 24.3511 |
| Retained Earnings (Accumulated Deficit) | -90.2193 | -77.4409 | -57.6711 | -36.5143 | -19.2612 |
| Total Liabilities & Shareholders’ Equity | 31.6591 | 33.9068 | 14.6976 | 20.0155 | 5.64332 |
| Total Common Shares Outstanding | 28.4266 | 24.9786 | 17.1007 | 11.469 | 9.93677 |
| Other Long Term Assets, Total | 0.51098 | 0.11904 | 0.1178 | 0.1178 | 0.3287 |
| Total Receivables, Net | 2.14885 | 3.11798 | 0.09523 | ||
| Other Current Assets, Total | 7.87953 | 1.61173 | 0.02408 | ||
| Current Port. of LT Debt/Capital Leases | 7.15037 | 0.09754 | |||
| Long Term Debt | 0 | 0.36581 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Total Current Assets | 30.3986 | 29.8769 | 23.4593 | 29.495 | 28.0252 |
| Cash and Short Term Investments | 26.7163 | 19.4618 | 13.5009 | 27.1768 | 24.907 |
| Cash | 26.7163 | 19.4618 | 13.5009 | 27.1768 | 24.907 |
| Total Receivables, Net | 1.85222 | 2.14885 | 1.25767 | 1.17134 | 1.17891 |
| Prepaid Expenses | 1.79656 | 0.38663 | 0.77768 | 1.04895 | 1.089 |
| Other Current Assets, Total | 0.03358 | 7.87953 | 7.92312 | 0.09787 | 0.85025 |
| Total Assets | 40.1881 | 31.6591 | 24.9916 | 30.5829 | 28.8517 |
| Property/Plant/Equipment, Total - Net | 1.37036 | 1.27123 | 1.4132 | 0.96888 | 0.70742 |
| Other Long Term Assets, Total | 8.41907 | 0.51098 | 0.11904 | 0.11904 | 0.11904 |
| Total Current Liabilities | 10.3788 | 11.1725 | 20.7194 | 14.5598 | 16.3656 |
| Accounts Payable | 1.53476 | 1.6141 | 1.68473 | 1.66763 | 1.81512 |
| Accrued Expenses | 1.05726 | 2.32693 | 1.68645 | 1.86687 | 1.7253 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 7.74012 | 7.15037 | 7.28204 | 0.95976 | 0.78382 |
| Other Current Liabilities, Total | 0.04662 | 0.08109 | 10.0662 | 10.0656 | 12.0414 |
| Total Liabilities | 10.3939 | 11.1924 | 20.7454 | 21.5924 | 16.7115 |
| Total Long Term Debt | 0 | 0 | 0 | 6.99489 | 0.30729 |
| Long Term Debt | 0 | 0 | 6.99489 | 0.30729 | |
| Other Liabilities, Total | 0.01508 | 0.01995 | 0.02606 | 0.03763 | 0.03863 |
| Total Equity | 29.7942 | 20.4666 | 4.24614 | 8.99056 | 12.1401 |
| Redeemable Preferred Stock | 0 | 0 | 0 | ||
| Common Stock | 0.00317 | 0.00284 | 0.0026 | 0.0026 | 0.00256 |
| Additional Paid-In Capital | 127.35 | 110.683 | 97.4461 | 96.6219 | 94.9301 |
| Retained Earnings (Accumulated Deficit) | -97.559 | -90.2193 | -93.2026 | -87.634 | -82.7926 |
| Total Liabilities & Shareholders’ Equity | 40.1881 | 31.6591 | 24.9916 | 30.5829 | 28.8517 |
| Total Common Shares Outstanding | 31.6984 | 28.4266 | 25.9632 | 25.9466 | 25.6236 |
- Annual
- Quarterly
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Cash From Operating Activities | -20.8744 | -6.38428 | -18.9193 | -13.1111 | -4.73111 |
| Cash From Operating Activities | 0.22156 | 0.09542 | 0.01534 | 0.01913 | 0.02547 |
| Non-Cash Items | 2.43593 | 2.48317 | 2.51194 | 1.61547 | 0.41231 |
| Cash Taxes Paid | |||||
| Cash Interest Paid | 0.22717 | 0.01397 | |||
| Changes in Working Capital | -10.7535 | 10.807 | -0.28984 | 2.50737 | -0.0389 |
| Cash From Investing Activities | -1.61852 | -0.26126 | -0.16664 | -0.02791 | -0.01023 |
| Capital Expenditures | -1.22658 | -0.26126 | -0.16664 | -0.02791 | -0.01023 |
| Other Investing Cash Flow Items, Total | -0.39194 | ||||
| Cash From Financing Activities | 21.458 | 20.8648 | 13.5104 | 27.6177 | 6.60357 |
| Issuance (Retirement) of Stock, Net | 14.7299 | 20.8766 | 13.5104 | 27.6177 | 6.60357 |
| Net Change in Cash | -1.03498 | 14.2192 | -5.5756 | 14.4787 | 1.86222 |
| Issuance (Retirement) of Debt, Net | 6.72802 | -0.01186 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -7.33967 | -12.7784 | -15.7617 | -10.1931 | -5.35167 |
| Cash From Operating Activities | -8.1844 | -20.8744 | -14.9978 | -9.90314 | -4.57385 |
| Cash From Operating Activities | 0.07543 | 0.22156 | 0.14825 | 0.07524 | 0.03328 |
| Non-Cash Items | 0.9352 | 2.43593 | 1.65033 | 1.30978 | 0.65691 |
| Cash Interest Paid | 0.09559 | 0.22717 | 0.13184 | 0.07046 | 0.004 |
| Changes in Working Capital | -1.85537 | -10.7535 | -1.03471 | -1.0951 | 0.08763 |
| Cash From Investing Activities | -0.20766 | -1.61852 | -1.16507 | -0.64774 | -0.34432 |
| Capital Expenditures | -0.17457 | -1.22658 | -1.16507 | -0.64774 | -0.34432 |
| Cash From Financing Activities | 15.6465 | 21.458 | 9.16692 | 9.3559 | 1.45339 |
| Financing Cash Flow Items | -0.08339 | 0 | |||
| Issuance (Retirement) of Stock, Net | 15.8417 | 14.7299 | 2.28079 | 2.23408 | 1.53099 |
| Issuance (Retirement) of Debt, Net | -0.11179 | 6.72802 | 6.88612 | 7.12182 | -0.0776 |
| Net Change in Cash | 7.25442 | -1.03498 | -6.99596 | -1.19499 | -3.46478 |
| Cash Taxes Paid | 0 | 0 | |||
| Other Investing Cash Flow Items, Total | -0.0331 | -0.39194 |
| Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
|---|---|---|---|---|---|---|
| Grant (Stuart M) | Individual Investor | 14.2096 | 5132677 | 21753 | 2022-12-30 | LOW |
| Eshelman (Fredric N) | Individual Investor | 4.4624 | 1611872 | -6963 | 2022-11-10 | LOW |
| Ianchulev (Tsontcho M.D.) | Individual Investor | 3.3016 | 1192562 | -21316 | 2022-12-27 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.5451 | 919322 | -8433 | 2022-12-31 | LOW |
| Medical Strategy GmbH | Investment Advisor | 1.922 | 694259 | 0 | 2022-09-30 | LOW |
| Avenue Capital Group | Investment Advisor/Hedge Fund | 1.5166 | 547807 | 547807 | 2022-12-31 | HIGH |
| Mario (Ernest B) | Individual Investor | 1.0595 | 382706 | 6963 | 2021-11-17 | LOW |
| Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.9314 | 336432 | 336432 | 2022-12-31 | LOW |
| Palisade Capital Management, LLC | Investment Advisor/Hedge Fund | 0.8721 | 315029 | 315029 | 2022-12-31 | LOW |
| Renaissance Technologies LLC | Hedge Fund | 0.7987 | 288500 | 24400 | 2022-12-31 | HIGH |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.72 | 260067 | 6056 | 2022-12-31 | LOW |
| Millennium Management LLC | Hedge Fund | 0.2507 | 90568 | 14153 | 2022-12-31 | HIGH |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.2035 | 73517 | 11900 | 2022-12-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.1954 | 70581 | 1159 | 2022-12-31 | LOW |
| Mather (Charles E IV) | Individual Investor | 0.1953 | 70544 | 22222 | 2022-06-16 | LOW |
| Clasby (Jennifer G) | Individual Investor | 0.1842 | 66537 | 10835 | 2021-06-17 | |
| Lee (Kenneth B Jr) | Individual Investor | 0.1787 | 64544 | 22222 | 2022-06-16 | LOW |
| Bridgeway Capital Management, LLC | Investment Advisor | 0.1326 | 47900 | 0 | 2022-12-31 | LOW |
| Oak Family Advisors, LLC | Investment Advisor/Hedge Fund | 0.1276 | 46073 | -13113 | 2022-12-31 | MED |
| BNY Mellon Asset Management | Investment Advisor | 0.1228 | 44374 | -1136 | 2022-12-31 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
Leverage
1:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Eyenovia, Inc. Company profile
About Eyenovia Inc
Eyenovia, Inc. is a clinical stage ophthalmic company. The company is developing a pipeline of therapeutics based microdose array print (MAP) platform technology. Its pipeline is focused on the late-stage development of microdosed medications for progressive myopia, presbyopia, and mydriasis. The Company's product candidates include MydCombi, MicroPine and MicroLine. MydCombi is a combination micro-formulation product (phenylephrine-tropicamide) candidate for pharmacologic mydriasis (eye dilation). MicroPine is a topical therapy for the treatment of progressive myopia, a back-of-the-eye ocular disease associated with pathologic axial elongation and sclero-retinal stretching. MicroLine is a candidate, which is developing microdosed version of pilocarpine, an ophthalmic medication that can dose-dependently induce miosis, or a contraction of the pupil.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Eyenovia Inc revenues increased from $0K to $4M. Net loss increased 1% to $15.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Labor & Related Expenses in R&D increase of 53% to $3.9M (expense), Interest expense increase from $15K to $202K (expense).
| Industry: | Pharmaceuticals (NEC) |
295 Madison Ave Ste 2400
NEW YORK
NEW YORK 10017
US
Income Statement
- Annual
- Quarterly
News
GBP/EUR forecast: Will the pound rise against the euro in 2023?
The British pound has been moving sideways against the Euro, yet can it regain momentum? Read on for a GBP/EUR forecast.
16:27, 24 March 2023
Shiba Inu price prediction: Can the meme coin build on recent gains?
What’s next for the Shiba Inu meme coin after a sluggish 2022 so far? Read more…
12:51, 24 March 2023
Who are the biggest bitcoin mining companies?
Bitcoin mining is big business, but who are the biggest bitcoin mining companies?
12:06, 24 March 2023
USD/PKR forecast: Will Pakistan’s rupee continue to fall?
The rupee has rebounded against the dollar in recent months, will this trend continue?
11:49, 24 March 2023
Amazon stock forecast: Where next for AMZN amid massive layoffs?
Amazon has been making tens of thousands of its workers redundant. Does this affect the market’s baseline Amazon stock forecast?
10:46, 24 March 2023
Sweatcoin price prediction: What is Sweatcoin?
Can Sweatcoin run to the front of the crypto pack?
15:19, 23 March 2023
Who owns the most bitcoin?
Want to know who owns the most bitcoin? Learn more about the biggest bitcoin whales.
14:54, 23 March 2023People also watch
Still looking for a broker you can trust?
Join the 500.000+ traders worldwide that chose to trade with Capital.com